Anthos was founded by Blackstone Life Sciences and Novartis in 2019 to develop, manufacture, and commercialize abelacimab, a ...

Novartis chief executive says large pharma deals usually don't pay off. But the company remains interested in bolt-on ...

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

Novartis managers went through this type of ... Suspend your disbelief. Google chief executive Larry Page takes this approach. For years he fantasized about a search engine that would give people ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in P ...

WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...

announcing its first pharma partnerships with Eli Lilly and Novartis, worth almost $3 billion. The company – led by Google DeepMind Founder Demis Hassabis and formed just over two years ago ...

WASHINGTON, Jan 16 - Novartis (NOVN.S), opens new tab won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic ...